Početna › Mikrocelularni karcinom pluća › Nebraska
Kliničke studije za Mikrocelularni karcinom pluća u državi Nebraska
10 studija za Mikrocelularni karcinom pluća traži sudionike na lokacijama u državi Nebraska.
Gradovi u državi Nebraska
Službeni tekst studije (engleski)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT03460977177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- University of Nebraska Medical Center, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07472517Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Nebraska Cancer Specialists, Omaha
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07278479Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Oncology Hematology West PC, Omaha
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT07778316Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Nebraska Hematology-Oncology (NHO), Lincoln
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT06712355A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Nebraska Cancer Specialists, Grand Island
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06095505A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- University of Nebraska Medical Center, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06203210Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. ožu 2026. · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Nebraska Cancer Specialists, Omaha
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 18. velj 2026. · NCT07030257Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.